Phenominer Database Results (170 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
SD heart rate artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 436.0 beats/min 18.0 44.09 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98793 2160
SD heart rate artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 395.0 beats/min 5.0 12.25 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98799 2160
SD body weight artificial aortocaval fistula (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 291.0 g 6.0 14.7 body weighing method 1.0 ACF 2 days 98773 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.9 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98781 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.3 null 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98872 2160
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.8 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98876 2160
SD ejection fraction artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 75.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98884 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.8 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98844 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 3.8 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98850 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98854 2160
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 43.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99370 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 54.0 g/cm2 3.0 6.71 echocardiography 0.0 ACF 2 days 99396 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 72 days 5 2.1 % 0.1 0.22 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 2 days 99404 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 175 days 10 82.0 mmHg 4.0 12.65 vascular transducer tipped catheter 0.0 ACF 105 days 99222 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 7.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 ACF 28 days 99224 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8947.0 mmHg/s 745.0 2107.18 vascular transducer tipped catheter 0.0 ACF 28 days 99228 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 175 days 10 7.4 mm 0.3 0.95 echocardiography 0.0 ACF 105 days 99242 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 7.7 null 0.5 1.41 echocardiography 0.0 ACF 28 days heart left ventricle end-diastolic dimeter to posterior wall thickness ratio 99244 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 16.0 g/cm2 1.0 3.16 echocardiography 0.0 ACF 105 days 99250 2278
SD heart left ventricle interstitial angiotensin II level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial angiotensin II amount male 175 days 10 1.9 pg/hr 0.1 0.32 radioimmunoassay 0.0 ACF 105 days heart left ventricle interstitial angiotensin II level during a period of time 99262 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 86.0 mmHg 2.0 5.66 vascular transducer tipped catheter 0.0 ACF 28 days 99306 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 11.0 mmHg 1.0 2.24 vascular transducer tipped catheter 0.0 ACF 2 days 99308 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 9386.0 mmHg/s 260.0 581.38 vascular transducer tipped catheter 0.0 ACF 2 days 99324 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -5948.0 mmHg/s 131.0 370.52 vascular transducer tipped catheter 0.0 ACF 28 days 99338 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 8.2 mm 0.2 0.45 echocardiography 0.0 ACF 2 days 99340 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.3 mm 0.5 1.12 echocardiography 0.0 ACF 2 days 99348 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 lvedd/pw 5.8 null 0.2 0.45 echocardiography 0.0 ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99356 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 5.7 null 0.3 0.85 echocardiography 0.0 ACF 28 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99360 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 6971.0 mmHg/s 438.0 1072.88 vascular transducer tipped catheter 1.0 ACF 2 days 98888 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 71.0 mmHg 5.0 12.25 vascular transducer tipped catheter 1.0 ACF 5 days 98836 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 4.2 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 5 days 98783 2160
SD plasma epinephrine level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood epinephrine amount male 175 days 10 101.0 pg/ml 11.0 34.79 enzyme linked immunosorbent assay 0.0 ACF 105 days 99290 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.3 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 720 min 98787 2160
SD heart rate artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 419.0 beats/min 21.0 51.44 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98795 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 85.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 360 min 98806 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 7.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 360 min 98818 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 6.0 mmHg 1.0 2.45 vascular transducer tipped catheter 1.0 ACF 2 days 98822 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.2 null 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98868 2160
SD ejection fraction artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 65.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98878 2160
SD ejection fraction artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 75.0 % 3.0 7.35 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98882 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.5 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 720 min 98779 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.3 mm 0.1 0.24 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98862 2160
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 -6032.0 mmHg/s 387.0 947.95 vascular transducer tipped catheter 1.0 ACF 2 days 98890 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 175 days 10 4.8 g/kg 0.3 0.95 post excision weight measurement 0.0 ACF 105 days 99202 2278
SD heart right ventricle weight to body weight ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart right ventricle mass male 175 days 10 1.0 mg/g 0.1 0.32 post excision weight measurement 0.0 ACF 105 days 99210 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 6600.0 mmHg/s 289.0 913.9 vascular transducer tipped catheter 0.0 ACF 105 days 99230 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 50.0 % 3.0 6.71 echocardiography 0.0 ACF 2 days 99366 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 -4244.0 mmHg/s 222.0 702.03 vascular transducer tipped catheter 0.0 ACF 105 days 99234 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 14.0 g/cm2 3.0 8.49 echocardiography 0.0 ACF 28 days 99248 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 77.0 g/cm2 8.0 22.63 echocardiography 0.0 ACF 28 days 99252 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 80.0 g/cm2 6.0 18.97 echocardiography 0.0 ACF 105 days 99254 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 34.0 % 2.0 6.32 echocardiography 0.0 ACF 105 days 99258 2278
SD heart left ventricle interstitial angiotensin II level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial angiotensin II amount male 98 days 9 3.0 pg/hr 0.4 1.2 radioimmunoassay 0.0 ACF 28 days heart left ventricle interstitial angiotensin II level during a period of time 99260 2278
SD heart left ventricle interstitial norepinephrine level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial norepinephrine amount male 98 days 9 6.8 pg/hr 0.8 2.4 enzyme linked immunosorbent assay 0.0 ACF 28 days heart left ventricle interstitial bradykinin level during a period of time 99268 2278
SD heart left ventricle interstitial epinephrine level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial epinephrine amount male 175 days 10 8.6 pg/hr 1.1 3.48 enzyme linked immunosorbent assay 0.0 ACF 105 days heart left ventricle interstitial epinephrine level during a period of time 99274 2278
SD plasma norepinephrine level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood norepinephrine amount male 175 days 10 159.0 pg/ml 17.0 53.76 enzyme linked immunosorbent assay 0.0 ACF 105 days 99286 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 72 days 5 89.0 mmHg 3.0 6.71 vascular transducer tipped catheter 0.0 ACF 2 days 99300 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 10.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 ACF 28 days 99314 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 -7879.0 mmHg/s 530.0 1185.12 vascular transducer tipped catheter 0.0 ACF 2 days 99334 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 10.2 mm 0.2 0.57 echocardiography 0.0 ACF 28 days 99346 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 5.9 mm 0.2 0.57 echocardiography 0.0 ACF 28 days 99354 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 48.0 % 5.0 11.18 echocardiography 0.0 ACF 2 days ledd/pw 99364 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 8 3.2 % 0.1 0.28 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 28 days 99410 2278
SD plasma epinephrine level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood epinephrine amount male 98 days 9 91.0 pg/ml 21.0 63.0 enzyme linked immunosorbent assay 0.0 ACF 28 days 99288 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 71.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98810 2160
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.6 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98789 2160
SD heart rate artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 405.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98797 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 70.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 720 min 98808 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 5.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 720 min 98820 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 7.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 5 days 98824 2160
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 8.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98828 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.1 null 0.5 1.22 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98866 2160
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 5.9 null 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 98870 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.4 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98842 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 8.1 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98846 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.4 0.98 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98852 2160
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 37.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99368 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 10.1 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99236 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 6.3 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99240 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 lvedd/pw 7.9 null 0.4 1.26 echocardiography 0.0 ACF 105 days heart left ventricle end-diastolic dimeter to posterior wall thickness ratio 99246 2278
SD heart left ventricle interstitial epinephrine level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial epinephrine amount male 98 days 9 5.3 pg/hr 0.9 2.7 enzyme linked immunosorbent assay 0.0 ACF 28 days heart left ventricle interstitial epinephrine level during a period of time 99272 2278
SD plasma angiotensin II level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood angiotensin II amount male 175 days 10 65.0 pg/ml 13.0 41.11 radioimmunoassay 0.0 ACF 105 days 99278 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 57.0 mmHg 4.0 8.94 vascular transducer tipped catheter 0.0 ACF 2 days 99318 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 8.0 mm 0.1 0.22 echocardiography 0.0 ACF 2 days 99342 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle mass male 175 days 10 3.1 mg/g 0.1 0.32 post excision weight measurement 0.0 ACF 105 days 99206 2278
SD heart right ventricle weight to body weight ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart right ventricle mass male 98 days 8 0.9 mg/g 0.1 0.28 post excision weight measurement 0.0 ACF 28 days 99208 2278
SD lung weight artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. lung mass male 175 days 10 2.44 g 0.11 0.35 post excision weight measurement 0.0 ACF 105 days 99214 2278
SD heart rate artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 175 days 10 220.0 beats/min 5.0 15.81 vascular transducer tipped catheter 0.0 ACF 105 days 99218 2278
SD ejection fraction artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98 days 8 71.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99378 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 62.0 g/cm2 6.0 16.97 echocardiography 0.0 ACF 28 days 99402 2278
SD body weight artificial aortocaval fistula (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 302.0 g 5.0 12.25 body weighing method 1.0 ACF 360 min 98755 2160
SD heart rate artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 420.0 beats/min 14.0 34.29 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98801 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 74.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 5 days 98812 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 61.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 720 min 98832 2160
SD heart rate artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 307.0 beats/min 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99296 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8116.0 mmHg/s 348.0 984.29 vascular transducer tipped catheter 0.0 ACF 28 days 99328 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 98 days 8 6.8 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99352 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 lvedd/pw 5.4 null 0.4 0.89 echocardiography 0.0 ACF 2 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99358 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 13.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98826 2160
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.6 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 2 days 98874 2160
SD body weight artificial aortocaval fistula (for 12 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 267.0 g 4.0 9.8 body weighing method 1.0 ACF 720 min 98771 2160
SD body weight artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 281.0 g 4.0 9.8 body weighing method 1.0 ACF 5 days 98775 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.4 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98860 2160
SD body weight artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. body mass male 98 days 8 354.0 g 9.0 25.46 scale 0.0 ACF 28 days 99192 2278
SD body weight artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. body mass male 175 days 10 489.0 g 15.0 47.43 scale 0.0 ACF 105 days 99194 2278
SD heart weight artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 98 days 8 1.55 g 0.06 0.17 post excision weight measurement 0.0 ACF 28 days 99196 2278
SD heart weight to body weight ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 98 days 8 4.4 g/kg 0.2 0.57 post excision weight measurement 0.0 ACF 28 days 99200 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle mass male 98 days 8 3.1 mg/g 0.1 0.28 post excision weight measurement 0.0 ACF 28 days 99204 2278
SD lung weight artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. lung mass male 98 days 8 1.84 g 0.08 0.23 post excision weight measurement 0.0 ACF 28 days 99212 2278
SD heart rate artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 271.0 beats/min 11.0 31.11 vascular transducer tipped catheter 0.0 ACF 28 days 99216 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 95.0 mmHg 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99220 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 39.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99369 2278
SD ejection fraction artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72 days 5 76.0 % 5.0 11.18 echocardiography 0.0 ACF 2 days 99372 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -6995.0 mmHg/s 458.0 1295.42 vascular transducer tipped catheter 0.0 ACF 28 days 99232 2278
SD heart left ventricle interstitial norepinephrine level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial norepinephrine amount male 175 days 10 10.2 pg/hr 1.0 3.16 enzyme linked immunosorbent assay 0.0 ACF 105 days heart left ventricle interstitial bradykinin level during a period of time 99270 2278
SD heart rate artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72 days 5 375.0 beats/min 12.0 26.83 vascular transducer tipped catheter 0.0 ACF 2 days 99294 2278
SD heart rate artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 98 days 8 316.0 beats/min 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99298 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 11.0 mmHg 2.0 4.47 vascular transducer tipped catheter 0.0 ACF 2 days 99310 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 9065.0 mmHg/s 354.0 791.57 vascular transducer tipped catheter 0.0 ACF 2 days 99326 2278
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 8937.0 mmHg/s 423.0 1196.42 vascular transducer tipped catheter 0.0 ACF 28 days 99330 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 -8797.0 mmHg/s 411.0 919.02 vascular transducer tipped catheter 0.0 ACF 2 days 99332 2278
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 -6834.0 mmHg/s 333.0 941.87 vascular transducer tipped catheter 0.0 ACF 28 days 99337 2278
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-systolic diameter male 72 days 5 4.0 mm 0.2 0.45 echocardiography 0.0 ACF 2 days 99350 2278
SD heart left ventricle end-diastolic diameter to posterior wall thickness ratio artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 lvedd/pw 6.0 null 0.4 1.13 echocardiography 0.0 ACF 28 days heart left ventricle end-diastolic diameter to posterior wall thickness ratio 99362 2278
SD ejection fraction artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 98 days 8 63.0 % 2.0 5.66 echocardiography 0.0 ACF 28 days 99376 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 16.0 g/cm2 1.0 2.24 echocardiography 0.0 ACF 2 days 99388 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 16.0 g/cm2 4.0 8.94 echocardiography 0.0 ACF 2 days 99390 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 81.0 g/cm2 8.0 22.63 echocardiography 0.0 ACF 28 days 99400 2278
SD heart rate artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then xylazine (10 mg/kg) and ketamine (80 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart pumping trait male 0 days 6 378.0 beats/min 10.0 24.49 HP Sonos 5500 echo ultrasound 1.0 ACF 2 days 98803 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 71.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 2 days 98816 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 72.0 mmHg 4.0 9.8 vascular transducer tipped catheter 1.0 ACF 360 min 98830 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 56.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 2 days 98834 2160
SD maximum rate of positive change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 8259.0 mmHg/s 325.0 796.08 vascular transducer tipped catheter 1.0 ACF 2 days 98886 2160
SD plasma bradykinin level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood bradykinin amount male 98 days 9 28.0 pg/ml 2.0 6.0 radioimmunoassay 0.0 ACF 28 days 99280 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 10.0 mmHg 1.0 2.83 vascular transducer tipped catheter 0.0 ACF 28 days 99312 2278
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 15.0 g/cm2 2.0 5.66 echocardiography 0.0 ACF 28 days 99392 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.7 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 5 days 98791 2160
SD ejection fraction artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. cardiac output trait male 0 days 6 66.0 % 4.0 9.8 HP Sonos 5500 echo ultrasound 1.0 ACF 720 min 98880 2160
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-diastolic diameter male 0 days 6 7.9 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98848 2160
SD heart left ventricle end-systolic diameter artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle end-systolic diameter male 0 days 6 4.1 mm 0.5 1.22 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98856 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.4 mm 0.2 0.49 HP Sonos 5500 echo ultrasound 1.0 ACF 360 min 98858 2160
SD maximum rate of negative change in left ventricular blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 -5661.0 mmHg/s 312.0 764.24 vascular transducer tipped catheter 1.0 ACF 2 days 98892 2160
SD heart weight to body weight ratio artificial aortocaval fistula (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart mass male 0 days 6 g/g*103 3.3 g/kg 0.1 0.24 post excision weight measurement 1.0 ACF 360 min 98777 2160
SD ejection fraction artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. cardiac output trait male 72 days 5 79.0 % 3.0 6.71 echocardiography 0.0 ACF 2 days 99374 2278
SD heart weight artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart mass male 175 days 10 2.23 g 0.11 0.35 post excision weight measurement 0.0 ACF 105 days 99198 2278
SD left ventricular end-diastolic blood pressure artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 175 days 10 9.0 mmHg 1.0 3.16 vascular transducer tipped catheter 0.0 ACF 105 days 99226 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 11.6 mm 0.4 1.26 echocardiography 0.0 ACF 105 days 99238 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 38.0 % 2.0 5.66 echocardiography 0.0 ACF 28 days 99256 2278
SD heart left ventricle interstitial bradykinin level during a period of time artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial bradykinin amount male 98 days 9 9.3 pg/hr 1.1 3.3 radioimmunoassay 0.0 ACF 28 days heart left ventricle interstitial bradykinin level during a period of time 99264 2278
SD heart left ventricle interstitial bradykinin level during a period of time artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial bradykinin amount male 175 days 10 12.4 pg/hr 1.7 5.38 radioimmunoassay 0.0 ACF 105 days heart left ventricle interstitial bradykinin level during a period of time 99266 2278
SD plasma angiotensin II level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood angiotensin II amount male 98 days 9 107.0 pg/ml 7.0 21.0 radioimmunoassay 0.0 ACF 28 days 99276 2278
SD plasma norepinephrine level artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood norepinephrine amount male 98 days 9 89.0 pg/ml 8.0 24.0 enzyme linked immunosorbent assay 0.0 ACF 28 days 99284 2278
SD heart rate artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart pumping trait male 72 days 5 367.0 beats/min 8.0 17.89 vascular transducer tipped catheter 0.0 ACF 2 days 99292 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 72 days 5 84.0 mmHg 5.0 11.18 vascular transducer tipped catheter 0.0 ACF 2 days 99302 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 61.0 mmHg 3.0 6.71 vascular transducer tipped catheter 0.0 ACF 2 days 99316 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 70.0 mmHg 3.0 8.49 vascular transducer tipped catheter 0.0 ACF 28 days 99322 2278
SD left ventricle end-systolic wall stress artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 72 days 5 37.0 g/cm2 7.0 15.65 echocardiography 0.0 ACF 2 days 99398 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 7 2.4 % 0.1 0.26 ex vivo light microscopy with histochemistry and digital image analysis 0.0 sham ACF 28 days 99408 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 98 days 8 3.5 % 0.1 0.28 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 28 days 99409 2278
SD heart left ventricle weight to body weight ratio artificial aortocaval fistula (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle mass male 0 days 6 g/g*103 2.2 mg/g 0.1 0.24 post excision weight measurement 1.0 ACF 360 min 98785 2160
SD mean arterial blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. arterial blood pressure trait male 0 days 6 72.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98814 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 56.0 mmHg 3.0 7.35 vascular transducer tipped catheter 1.0 ACF 2 days 98838 2160
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 2 days) then metoprolol (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricular blood pressure trait male 0 days 6 57.0 mmHg 2.0 4.9 vascular transducer tipped catheter 1.0 ACF 2 days 98840 2160
SD heart left ventricle end-diastolic posterior wall thickness artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. heart left ventricle posterior wall thickness male 0 days 6 1.5 mm 0.3 0.73 HP Sonos 5500 echo ultrasound 1.0 ACF 5 days 98864 2160
SD left ventricle end-diastolic wall stress artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 16.0 g/cm2 2.0 5.66 echocardiography 0.0 ACF 28 days 99394 2278
SD ratio of the area occupied by interstitial collagen to the total area of the heart left ventricle artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle interstitial collagen amount male 72 days 5 3.6 % 0.2 0.45 ex vivo light microscopy with histochemistry and digital image analysis 0.0 ACF 2 days 99406 2278
SD plasma bradykinin level artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. blood bradykinin amount male 175 days 10 29.0 pg/ml 5.0 15.81 radioimmunoassay 0.0 ACF 105 days 99282 2278
SD mean arterial blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. arterial blood pressure trait male 98 days 8 90.0 mmHg 2.0 5.66 vascular transducer tipped catheter 0.0 ACF 28 days 99304 2278
SD left ventricular end-systolic blood pressure artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricular blood pressure trait male 98 days 8 75.0 mmHg 2.0 5.66 vascular transducer tipped catheter 0.0 ACF 28 days 99320 2278
SD heart left ventricle end-diastolic diameter artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 10.6 mm 0.3 0.85 echocardiography 0.0 ACF 28 days 99344 2278